Vaxil Bio Ltd V.VXL

Alternate Symbol(s): VXLLF

Healthcare Biotechnology

Vaxil Bio Ltd. is a Canada-based biotechnology company. The Company is focused on a drug discovery and development platform based on Signal Peptides (SPs) which the Company deploys to fight infectious diseases and cancer. The Company’s most advanced product, ImMucin, a MUC1 SP-derived vaccine, completed a Phase I/II clinical trial in multiple myeloma. The Company also has a SP-based COVID-19 vaccine candidate and a SP-based tuberculosis vaccine / treatment candidate. In addition, The Company has mAb candidates for the treatment of oncology and infectious diseases to be used alone, and in combination with other treatments. It has also initiated a pre-clinical program for a drug delivery polymer that targets high affinity E-selectin (P-Esbp), which the Company licensed for development and commercialization from BGN Technologies. It exploits the properties of SP domains on crucial proteins to develop targeted therapies against cancer targets and infectious disease pathogens.

TSXV:VXL - Post by User

Vaxil Bio Ltd > -----1 MORE TRADING DAY----

<< Previous

Bullboard Posts

Next >>

Comment by 90guppyon Jun 23, 2020 2:16pm

69 Views

Post# 31182044

RE:-----1 MORE TRADING DAY----

Anyday now we will see how much the insider participated. Dr. Ari Kellen is one, He is one big shot dude, having earned the most salary in Valeant in 2014 when he was an executive, That year he earned more than $50 million in compensation, he is not a smallfish, same as Dr, Shawn Langer, these two former MacKinsey Senior partners are big fishes.